Corpus ID: 237485222

Scaffold-Induced Molecular Graph (SIMG): Effective Graph Sampling Methods for High-Throughput Computational Drug Discovery

@inproceedings{Clyde2021ScaffoldInducedMG,
  title={Scaffold-Induced Molecular Graph (SIMG): Effective Graph Sampling Methods for High-Throughput Computational Drug Discovery},
  author={Austin R. Clyde and Ashka Shah and Max Zvyagin and Arvind Ramanathan and Rick L. Stevens},
  year={2021}
}
Scaffold based drug discovery (SBDD) is a technique for drug discovery which pins chemical scaffolds as the framework of design. Scaffolds, or molecular frameworks, organize the design of compounds into local neighborhoods. We formalize scaffold based drug discovery into a network design. Utilizing docking data from SARS-CoV-2 virtual screening studies and JAK2 kinase assay data, we showcase how a scaffold based conception of chemical space is intuitive for design. Lastly, we highlight the… Expand

Figures and Tables from this paper

References

SHOWING 1-10 OF 53 REFERENCES
DeepScaffold: a comprehensive tool for scaffold-based de novo drug discovery using deep learning
TLDR
A scaffold-based molecular generative model for drug discovery is proposed, which performs molecule generation based on a wide spectrum of scaffold definitions, including Bemis-Murko (BM) scaffolds, cyclic skeletons, and scaffolds with specifications on side-chain properties. Expand
Scaffold-based molecular design with a graph generative model†
TLDR
A graph generative model that targets its use in scaffold-based molecular design and can simultaneously control multiple chemical properties despite the search space constrained by fixing the substructure is proposed. Expand
Classification of scaffold-hopping approaches.
TLDR
Four major categories of scaffold hopping are classified, namely heterocycle replacements, ring opening or closure, peptidomimetics and topology-based hopping, which are used by medicinal chemists to discover equipotent compounds with novel backbones that have improved properties. Expand
Computational design of new molecular scaffolds for medicinal chemistry, part II: generalization of analog series-based scaffolds
TLDR
Generalization of the ASB scaffold approach has yielded a large knowledge base of scaffold-capturing compound series and target information. Expand
ScaffoldGraph: an open-source library for the generation and analysis of molecular scaffold networks and scaffold trees
TLDR
ScaffoldGraph integrates scaffold graph analysis into the growing scientific/cheminformatics Python stack, increasing the flexibility and extendibility of the tool compared to existing software. Expand
Structure-Based Drug Discovery
  • L. Tari
  • Engineering
  • Methods in Molecular Biology
  • 2012
1. The Utility of Structural Biology in Drug Discovery Leslie W. Tari 2. Genetic Construct Design and Recombinant Protein Expression for Structural Biology Suzanne C. Edavettal, Michael J. Hunter,Expand
Exploring chemical space for drug discovery using the chemical universe database.
TLDR
Open access sources of molecules, the classification and representation of chemical space using molecular quantum numbers (MQN), its exhaustive enumeration in form of the chemical universe generated databases (GDB), and examples of using these databases for prospective drug discovery are discussed. Expand
Novel Scaffold Fingerprint (SFP): Applications in Scaffold Hopping and Scaffold-Based Selection of Diverse Compounds
TLDR
A novel strategy is introduced that uses diverse scaffold selections using this SFP descriptor combined with R-group selection at the different substitution sites to identify novel structurally different and synthetically accessible chemotypes. Expand
rdScaffoldNetwork: The Scaffold Network Implementation in RDKit
TLDR
An implementation of the scaffold network in the open source cheminformatics toolkit RDKit allows an enhanced flexibility in terms of customizing the fragmentation rules, and enables the inclusion of atom- and bond-generic scaffolds into the network. Expand
SMILES-based deep generative scaffold decorator for de-novo drug design
TLDR
A new SMILES-based molecular generative architecture that generates molecules from scaffolds and can be trained from any arbitrary molecular set and serves as a data augmentation technique and is readily coupled with randomized SMilES to obtain even better results with small sets. Expand
...
1
2
3
4
5
...